Children with growth hormone insensitivity syndrome will be treated with insulin-like growth factor I. Eight of the patients to be studied have been involved in long term treatment with IGF-I in GCRC Project 817. In addition, new patients who are discovered with this rare disorder will be aded to the present protocol. One such patient has already been identified.
Showing the most recent 10 out of 782 publications